Parkside Financial Bank & Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38	Closed	-$169	–	2748
2024 Q4	$169	Buy	+38	New	+$154	﹤0.01%	2076
2024 Q3	–	Sell	-80	Closed	-$522	–	2116
2024 Q2	$522	Buy	80 +65	+433%	+$460	﹤0.01%	1762
2024 Q1	$131	Buy	+15	New	+$182	﹤0.01%	2004
2023 Q4	–	Sell	-131	Closed	-$1.26K	–	2123
2023 Q3	$1.26K	Buy	131 +116	+773%	+$1.14K	﹤0.01%	1778
2023 Q2	$160	Sell	15 -1	-6%	-$11	﹤0.01%	1976
2023 Q1	$169	Sell	16 -10	-38%	-$112	﹤0.01%	1967
2022 Q4	$322	Hold	26	–	–	﹤0.01%	1937
2022 Q3	$0	Buy	26 +15	+136%	+$170	﹤0.01%	1863
2022 Q2	$0	Buy	+11	New	+$130	﹤0.01%	1879

Other funds holding IRWD

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Parkside Financial Bank & Trust's IRWD Position: Q1 2025 in Review

Parkside Financial Bank & Trust sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 38 shares — an estimated $169 sold.

Parkside Financial Bank & Trust first reported a position in IRWD in Q2 2022 and held it in 9 quarters. The position peaked at $1.26K in Q3 2023. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

Parkside Financial Bank & Trust reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Parkside Financial Bank & Trust sold 38 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $169.
Parkside Financial Bank & Trust first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 9 quarters.
Parkside Financial Bank & Trust's Ironwood Pharmaceuticals position peaked at $1.26K in Q3 2023.
200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2025, filed 8 May 2025.